105 related articles for article (PubMed ID: 3630711)
1. The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin.
Frimodt-Møller N; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):159-65. PubMed ID: 3630711
[TBL] [Abstract][Full Text] [Related]
2. Experimental pneumococcus infection in mice: correlation of bactericidal activity in vitro with the effect in vivo for gentamicin, netilmicin and tobramycin.
Frimodt-Møller N; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):153-8. PubMed ID: 3630710
[TBL] [Abstract][Full Text] [Related]
3. Interaction between beta-lactam antibiotics and gentamicin against Streptococcus pneumoniae in vitro and in vivo.
Frimodt-Møller N; Frølund Thomsen V
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):269-75. PubMed ID: 3673584
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice.
Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 1999 Mar; 43(3):367-71. PubMed ID: 10223592
[TBL] [Abstract][Full Text] [Related]
5. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
6. Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone.
Frimodt-Møller N; Bentzon MW; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):261-7. PubMed ID: 3673583
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).
Dowling JN; Weyant RS; Pasculle AW
Antimicrob Agents Chemother; 1982 Aug; 22(2):272-6. PubMed ID: 6927637
[TBL] [Abstract][Full Text] [Related]
9. Do Prophylactic Antibiotics Reach the Operative Site Adequately?: A Quantitative Analysis of Serum and Wound Concentrations of Systemic and Local Prophylactic Antibiotics in Spine Surgery.
Naresh-Babu J; Arun-Kumar V
Spine (Phila Pa 1976); 2020 Feb; 45(4):E196-E202. PubMed ID: 31490860
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
12. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.
Houlihan HH; Stokes DP; Rybak MJ
J Antimicrob Chemother; 2000 Jul; 46(1):79-86. PubMed ID: 10882693
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.
Fass RJ; Barnishan J
J Antimicrob Chemother; 2001 Nov; 48(5):609-15. PubMed ID: 11679549
[TBL] [Abstract][Full Text] [Related]
15. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
[TBL] [Abstract][Full Text] [Related]
16. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of CI-934--a new quinolone derivative.
Finch R; Martin J; Pilkington R
Chemioterapia; 1986 Dec; 5(6):368-74. PubMed ID: 3467873
[TBL] [Abstract][Full Text] [Related]
18. Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique.
Bastani B; Amin K; Herr A
ASAIO J; 2005; 51(6):761-3. PubMed ID: 16340364
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.
Drouet M; Chai F; Barthélémy C; Lebuffe G; Debaene B; Décaudin B; Odou P
Antimicrob Agents Chemother; 2015 Aug; 59(8):4901-6. PubMed ID: 26055373
[TBL] [Abstract][Full Text] [Related]
20. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
Caron F; Lemeland JF; Humbert G; Klare I; Gutmann L
J Infect Dis; 1993 Sep; 168(3):681-6. PubMed ID: 8354909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
